mitapivat

USFDA Approves Agios Pharma’s Aqvesme for Alpha, Beta Thalassemia Anemia

DRRA1 week ago01 mins

[ad_1] USFDA Approves Agios Pharma’s Aqvesme for Alpha, Beta Thalassemia Anemia We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link

Agios shares slump on sickle cell disease data

DRRA2 months ago03 mins

[ad_1] Shares in Agios Pharma lost nearly half their value in pre-market trading today after it posted mixed clinical results from a phase 3 trial of its sickle cell disease (SCD) therapy mitapivat, sending its investors into a spin. In the pivotal RISE UP study, mitapivat – an orally-active pyruvate kinase (PKR) activator – was…

Connor Storrie’s Golden Globes Makeup Routine Revealed!

How to Avoid the Side Effects of GLP-1s When You Have Type 2 Diabetes

Dumbbell Bench Press Tips for Beginners: A Step-by-Step Guide

Vodka Sauce Creamy Butter Beans

Strength & Power Chest Workout: Maximize Gains in 45 Minutes

30-Minute Full Body Dumbbell Complex: Build Strength & Muscle

USFDA Approves Agios Pharma’s Aqvesme for Alpha, Beta Thalassemia Anemia

Agios shares slump on sickle cell disease data